Anteris Technologies Global Corp. — Director's Dealing 2019

May 30, 2019

Appendix 3Z Final Director’s Interest Notice

Rule 3.19A.3

Appendix 3Z

Final Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity	Admedus Limited
ABN	35 088 221 078

We (the entity) give ASX the following information under listing rule 3.19A.3 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of director	Lishan Zhang
Date of last notice	21 December 2018
Date that director ceased to be director	30 May 2019

Part 1 – Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & class of securities

• See chapter 19 for defined terms.

11/3/2002

Appendix 3Z Page 1

Appendix 3Z Final Director’s Interest Notice

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature of interest Note: Provide details of the circumstances giving rise to the relevant interest	Number & class of securities
Constellation Intl Holdings Limited Constellation Immunotherapy Limited Star Bright Holding Limited Carron Services Limited	73,019,140 ordinary shares Quoted options 30,424,624 Exercise price of $0.08 Exp 18 December 2021 40,209,208 ordinary shares Quoted options 16,753,837 Exercise price of $0.08 Exp 18 December 2021 17,367,943 ordinary shares Quoted options 14,528,310 Exercise price of $0.08 Exp 18 December 2021 2,857,144 ordinary shares Quoted options 1,190,470 Exercise price of $0.08 Exp 18 December 2021

Part 3 – Director’s interests in contracts

Detail of contract Nature of interest Name of registered holder (if issued securities) No. and class of securities to which interest relates

• See chapter 19 for defined terms.

Appendix 3Z Page 2

11/3/2002